Effectiveness of deltaran at chronic cerebral ischemia
Antipenko E.A., Gustov A.V., Chvatova E.M.
The choice of the treatment at chronic cerebral ischemia (CCI) is a problem due to various genesis of this pathology, the combination of the brain atrophy and cerebrovascular insufficiency, the present of concomitant diseases, differences of adaptive abilities at the different stages of CCI, individual capacities of human response. The arm of our study was to investigate the effectiveness of deltaran at CCI. Deltaran is known as neuropeptide with regulate action. Deltaran improves the effectiveness of the treatment for all stages of CCI.Deltaran significantly. Deltaran decreases the headache, vertigo and ataxia and sleep disorders. Deltaran has the nootropic action, especially for the 3 stage of CCI. Deltaran has regular anxiety and antidepressive effect, that confirm its adaptogene effect.